← Leaderboards
Eduard Chekmenev
Huntington Medical Research Institutes
$3,517,938
Attributed
$4,509,817
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,509,817 · 9
By mechanism
R21$2,424,330 · 6
R01$1,160,993 · 1
R00$809,733 · 1
K99$114,761 · 1
Top collaborators
- Boyd M Goodson4 shared
- Matthew Scot Rosen2 shared
Others in their field
Top investigators on “Nuclear”
- David W Simpson · University Of Southern California$143,628,960
- Polly Chang · Sri International$113,805,005
- Gregory S Boebinger · Florida State University$83,575,927
- Charles H Mielke · Florida State University$82,175,927
- Alan G Marshall · Florida State University$82,175,927
- Gaetano T Montelione · Rutgers The St Univ Of Nj New Brunswick$74,984,787
Research focus
NuclearProductionMagnetic Resonance ImagingImageIn VivoSignal TransductionContrast MediaResolutionCatalystMalignant NeoplasmsMetabolicMetabolismDetectionSiteCostDevicesMolecular ImagingProtonsMonitorGasesDesignResponseEquipmentMolecular
Grant awards (20)
Plug-and-play Hyperpolarized MRI of Metabolism on Clinical Scanners$593,996
R01 · FY2025 · EB
Next-generation Lasers for Enabling Ultrafast Functional Pulmonary MRI$147,395
R21 · FY2025 · HL · contact PI
Plug-and-play Hyperpolarized MRI of Metabolism on Clinical Scanners$566,997
R01 · FY2024 · EB
Next-generation Lasers for Enabling Ultrafast Functional Pulmonary MRI$231,207
R21 · FY2024 · HL · contact PI
Rapid low-cost production of contrast agents for metabolic imaging$218,771
R21 · FY2024 · EB · contact PI
Rapid low-cost production of contrast agents for metabolic imaging$195,785
R21 · FY2023 · EB · contact PI
Hyperpolarized Diethyl Ether for Sub-second Pulmonary MRI$228,593
R21 · FY2021 · HL · contact PI
Hyperpolarized Diethyl Ether for Sub-second Pulmonary MRI$190,271
R21 · FY2020 · HL · contact PI
Magnetic Resonance Spectroscopy and Molecular Imaging of Metabolic Pathways in Cancer$118,242
R21 · FY2019 · CA · contact PI
Magnetic Resonance Spectroscopy and Molecular Imaging of Metabolic Pathways in Cancer$135,400
R21 · FY2018 · CA · contact PI
Magnetic Resonance Spectroscopy and Molecular Imaging of Metabolic Pathways in Cancer$135,900
R21 · FY2017 · CA · contact PI
Pure parahydrogen-enhanced metabolic MRI contrast agents for molecular imaging$189,615
R21 · FY2016 · EB
Pure parahydrogen-enhanced metabolic MRI contrast agents for molecular imaging$226,197
R21 · FY2015 · EB
Pure parahydrogen-enhanced metabolic MRI contrast agents for molecular imaging$185,013
R21 · FY2015 · EB
Pure parahydrogen-enhanced metabolic MRI contrast agents for molecular imaging$221,941
R21 · FY2014 · EB
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancer$241,530
R00 · FY2011 · CA · contact PI
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancer$239,344
R00 · FY2010 · CA · contact PI
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancer$248,413
R00 · FY2009 · CA · contact PI
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancer$80,446
R00 · FY2009 · CA · contact PI
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancer$114,761
K99 · FY2008 · CA · contact PI